SS 35 - GI 2: Colorectal Cancer: Innovation through Preservation and Observation

Moderator(s)

• 

  Krishan Jethwa, MD

  Mayo Clinic College of Medicine and Science Rochester
  Rochester, MN, United States
• JD

  Jennifer Dorth, MD

  University Hospitals - Seidman Cancer Center
  Cleveland, Ohio, United States

Presentations:

• 2:30 PM – 2:40 PM ET

  Does Radiation Boost Dose Affect Organ Preservation Rates? A Secondary Analysis of the OPRA Trial
  

  Presenter: Orly Yariv, MD – National Cancer Inst
• 2:40 PM – 2:50 PM ET

  Phase II Trial of Organ Preservation Program Using Short-Course Radiation and Folfoxiri for Rectal Cancer (SHORT-FOX): Clinical Response Outcomes
  

  Presenter: Erqi Pollom, MD, MS – Stanford University
• 2:50 PM – 3:00 PM ET

  The New Sandwich Total Neoadjuvant Treatment (TNT) Strategy in Locally Advanced Rectal Cancer Patients: First Results of TESS Phase II Trial
  

  Presenter: WeiWei Xiao, MD, PhD – Sun Yat-Sen University Cancer Center
• 3:00 PM – 3:10 PM ET

  Radiation Quality Control in the PROSPECT Trial
  

  Presenter: Harvey Mamon, MD, PhD, FASTRO – Brigham and Women's Hospital/Dana-Farber
• 3:10 PM – 3:20 PM ET

  Patient Reported Quality of Life and Functional Outcomes after Pre-Operative Short- vs. Long-Course Radiotherapy for Rectal Adenocarcinoma
  

  Presenter: Syed Shah, MD
• 3:20 PM – 3:30 PM ET

  Discussant
  

  Discussant: Emma Holliday, MD – The University of Texas MD Anderson Cancer Center